Super-selective Intra-arterial Cerebral Infusion of Trastuzumab for the Treatment of Cerebral Metastases of HER2/Neu Positive Breast Cancer

NCT02571530 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Low enrollment

Conditions

Neoplasm Metastasis

Interventions

DRUG: Intra-arterial Cerebral Infusion of Trastuzumab

Sponsor

Northwell Health